Eating disorders are on the rise. GLP-1s could make things worse.
Clinical psychologists warn that GLP-1 weight-loss drugs may exacerbate eating disorders.
Stories tagged by our AI curator.
Clinical psychologists warn that GLP-1 weight-loss drugs may exacerbate eating disorders.
Biotech company ALLOX has secured $10.5 million in seed funding to advance its AI-driven drug discovery platform.
Anthropic has acquired Mithril Medicine, a single-founder biotech firm developing rare muscular dystrophy treatments, and launched its own drug discovery efforts.
Atlas Bio, a Swiss biotech startup, raised $12.5 million to develop an AI foundation model that simulates clinical trials and aims to replace Phase II drug trials and animal testing.
MIT Technology Review examines progress on six potentially transformative technologies that have long been promised, from pills enabling exercise to Mars missions, while also exploring limitations in biotech coverage.
Warhound, a startup co-founded by an Anduril cofounder, raises $200 million to combine biotechnology with defense technology for breeding military working dogs.
A podcast roundtable featuring three French founders building advanced cancer therapies through microalgae-based manufacturing, cell therapy, and AI-driven drug discovery discusses scaling European BioTech innovation.
University of Washington's protein design institute releases RFD4-Proteina, an open-source AI model co-developed with Nvidia for creating proteins with specific functions.
Cellbox Solutions, a German warm-chain logistics company, completed its €5 million Series A financing round to expand its platform for transporting sensitive biological materials.